Interferons (IFNs) are a diverse group of cytokines whose potent antitumor effects have piqued the interest of scientists for decades. Some of the most sustained clinical accomplishments have been in the field of myeloproliferative neoplasms (MPNs). Here, we discuss how both historical and novel breakthroughs in our understanding of IFN function may lead to more effective therapies for MPNs. The particular relevance and importance of modulating the novel IFN-regulated ULK1 pathway to optimize IFN responses is highlighted.
|Original language||English (US)|
|State||Published - Mar 2023|
- essential thrombocytosis
- myeloproliferative neoplasms
- polycythemia vera
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)